Journal article
Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.
Abstract
BACKGROUND: Adjuvant IFN-α treatment for patients with malignant melanoma is often complicated by depression. The influence of dosage, however, is unknown.
OBJECTIVE: The authors sought to elucidate this dosage effect.
Authors
Friebe A; Horn M; Schmidt F; Janssen G; Schmid-Wendtner M-H; Volkenandt M; Hauschild A; Goldsmith CH; Schaefer M
Journal
Journal of the Academy of Consultation-Liaison Psychiatry, Vol. 51, No. 6, pp. 466–473
Publisher
Elsevier
Publication Date
November 1, 2010
DOI
10.1176/appi.psy.51.6.466
ISSN
2667-2960